Inflammatory bowel diseases (IBD) are chronic inflammatory diseases with increasing prevalence in elderly patients. Multiple comorbidities associated with polypharmacy are to be considered in such patients and impose some limitations in the diagnosis and treatment of IBD. This literature minireview has the purpose of highlighting the particularities of the diagnosis and treatment of IBD in elderly patients. Frailty and sarcopenia are key findings in the geriatric population and need careful consideration and proper therapeutic approach when constructing the diagnosis protocol and treatment regimen in elderly patients with IBD. Considering that the treatment options for IBD in elderly patients are quite extensive, adherence to treatment is expected to be attained. Diagnosing this pathology in the elderly patients' group poses a great responsibility in weighing the risks and benefits of the procedures, as well as costs of hospitalization and comorbidities that can impede a timely diagnosis.